Cargando…

Anti-obesity pharmacotherapy for treatment of pediatric type 2 diabetes: Review of the literature and lessons learned from adults

Type 2 diabetes mellitus (T2DM) in adolescents is a more rapidly progressive disease, associated with earlier and higher rates of microvascular complications than in adults. As obesity is a significant risk factor for T2DM development and progression, the American Diabetes Association (ADA) recommen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bensignor, Megan O., Kelly, Aaron S., Arslanian, Silva
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647073/ https://www.ncbi.nlm.nih.gov/pubmed/36387846 http://dx.doi.org/10.3389/fendo.2022.1043650

Ejemplares similares

Glucagon‐like peptide‐1 receptor agonist prescribing patterns in adolescents with type 2 diabetes
por: Bensignor, Megan O., et al.
Publicado: (2022)

Recent Advances in Incretin-Based Pharmacotherapies for the Treatment of Obesity and Diabetes
por: Tan, Qiming, et al.
Publicado: (2022)

Pharmacotherapy for the Treatment of Overweight and Obesity in Children, Adolescents, and Young Adults in a Large Health System in the US
por: Czepiel, Kathryn S., et al.
Publicado: (2020)

Advances in Anti-obesity Pharmacotherapy: Current Treatments, Emerging Therapies, and Challenges
por: Brandfon, Skyler, et al.
Publicado: (2023)

The potential role of lactulose pharmacotherapy in the treatment and prevention of diabetes
por: Chu, Natural, et al.
Publicado: (2022)

Emerging Trend in the Pharmacotherapy of Osteoarthritis
por: Zhang, Wei, et al.
Publicado: (2019)

Impact of COVID-19 on Youth With Type 2 Diabetes: Lessons Learned From a Pediatric Endocrinologist and a Psychologist
por: Muñoz, Cynthia E., et al.
Publicado: (2021)

Efficacy of Weight Reduction on Pediatric Nonalcoholic Fatty Liver Disease: Opportunities to Improve Treatment Outcomes Through Pharmacotherapy
por: Friesen, Chance S., et al.
Publicado: (2021)

Characteristics of Obstructive Sleep Apnea Across the Spectrum of Glucose Tolerance in Obese Adolescents
por: Hannon, Tamara S., et al.
Publicado: (2018)

The Potential Role of Combination Pharmacotherapy to Improve Outcomes of Pediatric Obesity: A Case Report and Discussion
por: Fox, Claudia K., et al.
Publicado: (2018)

Endocrine FGFs: Evolution, Physiology, Pathophysiology, and Pharmacotherapy
por: Itoh, Nobuyuki, et al.
Publicado: (2015)

Effects of Pharmacotherapy for the Treatment of Obesity in an Urban, Safety-Net Population
por: Kim, Eric K, et al.
Publicado: (2023)

COVID-19 and Diabetes: A Comprehensive Review of Angiotensin Converting Enzyme 2, Mutual Effects and Pharmacotherapy
por: Xie, Lingli, et al.
Publicado: (2021)

It Is Time to Consider Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes in Youth
por: Oberle, Megan M., et al.
Publicado: (2019)

Fragile X targeted pharmacotherapy: lessons learned and future directions
por: Erickson, Craig A., et al.
Publicado: (2017)

OR33-1 Metabolic Inflexibility in Obese versus Lean Women with Polycystic Ovary Syndrome (PCOS): Is PCOS Status or Adiposity the Critical Factor?
por: Gebara, Nour, et al.
Publicado: (2019)

Pharmacotherapy for Obesity
por: Joo, Jong Kil, et al.
Publicado: (2014)

Stress induced obesity: lessons from rodent models of stress
por: Patterson, Zachary R., et al.
Publicado: (2013)

Pediatric Obesity: Complications and Current Day Management
por: Vajravelu, Mary Ellen, et al.
Publicado: (2023)

Cost-Effectiveness of Pharmacotherapy for the Treatment of Obesity in Adolescents
por: Lim, Francesca, et al.
Publicado: (2023)

Pharmacoeconomic evaluation of anti-obesity drugs for chronic weight management: a systematic review of literature
por: Xue, Yan, et al.
Publicado: (2023)

Cost-Effectiveness of Pharmacotherapy to Reduce Obesity
por: Veerman, J. Lennert, et al.
Publicado: (2011)

Obesity Pharmacotherapy in Patients With Type 2 Diabetes
por: Kahan, Scott, et al.
Publicado: (2017)

Maternal and infant outcomes in women with and without gestational diabetes mellitus in the COVID-19 era in China: Lessons learned
por: Zheng, Wei, et al.
Publicado: (2022)

Exploring the underlying mechanisms of obesity and diabetes and the potential of Traditional Chinese Medicine: an overview of the literature
por: Chen, Yan-kun, et al.
Publicado: (2023)

Predicting risk of obesity in overweight adults using interpretable machine learning algorithms
por: Lin, Wei, et al.
Publicado: (2023)

Clinical Considerations Regarding the Use of Obesity Pharmacotherapy in Adolescents with Obesity
por: Srivastava, Gitanjali, et al.
Publicado: (2019)

Weight and Glycemic Control Outcomes of Bariatric Surgery and Pharmacotherapy in Patients With Melanocortin-4 Receptor Deficiency
por: Fojas, Esphie Grace Fodra, et al.
Publicado: (2022)

Diabetes and Prediabetes in Children With Cystic Fibrosis: A Systematic Review of the Literature and Recommendations of the Italian Society for Pediatric Endocrinology and Diabetes (ISPED)
por: Mozzillo, Enza, et al.
Publicado: (2021)

Weight Loss From Combination Anti-Obesity Medication Regimens Can Approach that Achieved From Bariatric Surgery
por: Patel, Priya N, et al.
Publicado: (2023)

Comparison of novel markers of metabolic complications and cardiovascular risk factors between obese non-diabetic and obese type 1 diabetic children and young adults
por: Kącka, Anna, et al.
Publicado: (2022)

Genomic Medicine: Lessons Learned From Monogenic and Complex Bone Disorders
por: Trajanoska, Katerina, et al.
Publicado: (2020)

Lessons Learned From a Program to Reduce Diabetes Risk Among Low-Income Hispanic Women in a Community Health Clinic
por: Lindberg, Nangel M., et al.
Publicado: (2021)

Growth Hormone and Reproduction: Lessons Learned From Animal Models and Clinical Trials
por: Dosouto, Carlos, et al.
Publicado: (2019)

Pharmacotherapy of pediatric metabolic syndrome
por: Kelishadi, Roya, et al.
Publicado: (2013)

Pharmacotherapy for Pediatric Neurogenic Bladder
por: Kroll, Paweł
Publicado: (2017)

Monitoring of Pediatric Type 1 Diabetes
por: Marks, Brynn E., et al.
Publicado: (2020)

Antidiabetic and antiosteoporotic pharmacotherapies for prevention and treatment of type 2 diabetes-induced bone disease: protocol for two network meta-analyses
por: Deng, Jiawen, et al.
Publicado: (2020)

Pharmacotherapy in paediatric type 2 diabetes mellitus: a protocol for a systematic review and network meta-analysis of randomised trials
por: Zhou, Fangwen, et al.
Publicado: (2022)

Obesity pharmacotherapy: current status
por: Kumar, Parveen, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_iinahr59jrg6kjqfq4p7gu495l